Progesterone receptor inhibitor ACT-129968, Purity ≥98%

Synonym: 866460-33-5; Progesterone receptor inhibitor; ACT 129968; ACT129968; KYTH-105; KYTH105; KYTH 105; Setipiprant

Product Size

5 mg; 10 mg; 25 mg; 50 mg

Price

Datasheet

Datasheet

MSDS

MSDS

Properties

Description

ACT-129968, soluble in DMSO, is a compound that blocks the action of progesterone at its receptor sites. It targets EP2, hCRTH2, and hDP1.

Molecular Weight

402.43

Molecular Formula

C₂₄H₁₉FN₂O₃

Targets

EP2: 2600 nM; hCRTH2: 6 nM; hDP1: 1290 nM

Form

Lyophilized powder

Purity

≥98%

Solubility

DMSO: 69 mg/mL (171.46 mM);

Identity

Confirmed by NMR/HPLC/MS.

Applications

ACT-129968 is used to study progesterone receptor function, with potential applications in reproductive health and contraception.